Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

24,870 signal articles · 247 in last 24h · 118,518 total before filter · latest 18m ago
247last 24h
1554last 7d
256● bullish (7d)
162● bearish (7d)
205publishers
AllMacro300Earnings628M&A100Regulatory24Product14Analyst23
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Can Johnson Controls (JCI) Turn Wasted Heat Into $18B?
Insider Monkey8d agoneutral
Can Johnson Controls (JCI) Turn Wasted Heat Into $18B?

Johnson Controls International (NYSE:JCI) just found a way to sell power that the data center industry was throwing away. On July 28, the company launched its Absorption Chiller Reference Design Guide, a blueprint that converts waste heat from on-site generators into cooling capacity, freeing up electricity that would otherwise go to running chillers. In a […]

AbCellera (ABCL) Rockets 44% as Hot Flash Treatment Brightens Growth Outlook
Insider Monkey8d agoneutral
AbCellera (ABCL) Rockets 44% as Hot Flash Treatment Brightens Growth Outlook

AbCellera Biologics Inc. (NASDAQ:ABCL) rallied for a third consecutive day on Monday to hit a new three-year high, after its drug candidate for hot flashes in menopausal women achieved strong clinical trial results, sparking long-term rosy growth prospects. In intra-day trading, the stock surged to a record high of $10.01 before trimming gains to end […]

Eli Lilly vs. Novo Nordisk: Has GLP-1 Manufacturing Become the New Competitive Moat?
Insider Monkey8d agoneutral
Eli Lilly vs. Novo Nordisk: Has GLP-1 Manufacturing Become the New Competitive Moat?

The obesity-drug market has largely been viewed as a race between clinical innovation and commercial execution. Investors have spent the past three years comparing prescription growth, market share, and pipeline candidates as Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) compete for dominance in one of healthcare’s fastest-growing markets. Yet another competitive advantage for investors to […]